The Hospital Clínic de Barcelona-IDIBAPS has developed a new CAR-T treatment for multiple myeloma, the second most common blood cancer, with encouraging results: “all patients improve, 75% of them maintain the response and not they have disease progression at 12 months, and 60% have complete remission without residual disease “, says Dr. Fernández de Larrea, [...]
20 December 2021
CIENCIA EXPLORACIÓN ESPACIAL RESEARCH AND INNOVATION
La Universidad Miguel Hernández utiliza cookies propias y de terceros para fines analíticos y respetar tus preferencias de navegación. En nuestra política de cookies encontrarás más información. Si continuas navegando o pulsas sobre el botón "Aceptar", consideramos que aceptas su uso. Si por el contrario quieres rechazarlas pulsa sobre "Rechazar" y te indicaremos cómo debes hacerlo.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.